February 7, 2019 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships Mass Spectrometry

Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a unique effort of six academic institutions and five life science and pharma companies that utilizes both mass cytometry and Imaging Mass Cytometry™ along with other technologies to explore the common cellular basis of... Read more

January 28, 2019 Cell Analysis Tools Product Launch

Bio-Techne Introduces CE-SDS PLUS for Maurice™ System

Minneapolis, January 28, 2019/PRNewswire/ — Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice™ platform. This new system further expands the usability of Maurice’s proprietary cartridge and reduces undesirable protein fragmentation during separation. Since its introduction in 2016, Maurice has enabled capillary electrophoresis – sodium dodecyl sulfate (CE-SDS) for size-based... Read more

January 24, 2019 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools Product Launch

BIO-TECHNE LAUNCHES CELL AND GENE THERAPY PORTFOLIO

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more

January 8, 2019 Cell Analysis Tools Product Launch

FUJIFILM Cellular Dynamics Inc. Launches New Product iCell Microglia, an iPSC-Derived Neural Cell Type

hiPSC-derived microglia are utilized with the aim of advancing research to fulfill unmet medical needs for patients with neurodegenerative diseases MADISON, Wis., January 08, 2019 — FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and tissue-specific cells differentiated from iPSCs, has announced the launch of its... Read more

January 3, 2019 Cell Analysis Tools M&A, Partnerships

FUJIFILM Cellular Dynamics to Establish New Facility for Production of Human iPS Cell Therapy Applications

Fujifilm is investing in the cGMP-compliant facility located in Madison, Wisconsin with the goal to begin operations by March 2020 MADISON, Wis., January 3, 2019 — FUJIFILM Cellular Dynamics, Inc. (FCDI), a US subsidiary of FUJIFILM Corporation (President: Kenji Sukeno) and a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies,... Read more

January 3, 2019 Cell Analysis Tools Chromatography Life Science Tools Liq. Handling & Robotics Mass Spectrometry PR/Corporate

Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019

Date: 01/03/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current... Read more

January 2, 2019 Cell Analysis Tools Lab Top-10 M&A, Partnerships

Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio

AUSTIN, Texas, Jan. 2, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma’s flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases. The acquisition is expected to contribute $40 million to $50 million in revenue to Luminex in 2019. “We are pleased... Read more

January 2, 2019 Cell Analysis Tools Licensing, IP, and Legal

Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration

Madison, WI USA. (January 2, 2019) Promega Corporation’s latest microsatellite instability (MSI) technology has been granted innovation designation by the Chinese National Medical Products Administration (NMPA). Promega MSI technology has been validated in labs around the world. With innovation status, the path to become classified as an invitro diagnostic (IVD) will gain elevated efficiency by having... Read more

December 14, 2018 Cell Analysis Tools PR/Corporate

Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

PDF Version SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its previously announced underwritten public offering of 9,372,500 shares of its common stock. The stock was sold at a price to the public of $6.75 per share, for aggregate gross proceeds of... Read more

December 13, 2018 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services

December 18, 2018 ~ Services and Capacity Increase with New Site Opening ~ (San Diego, Calif., December 13, 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening... Read more